The Effect of Flutamide on Ovulation Induction in PCOS Patients

Background Polycystic ovary syndrome (PCOS) is a disorder that affects various body organs and requires comprehensive long term evaluation and management. The aim of this study was to evaluate effect of Flutamide on ovulation induction in PCOS patients. Materials and Methods This prospective study applied triple blind method, a simple convenience sampling method, to induce ovulations of the ninety six PCOS patients. Patients were divided into two groups; group A included 53 subjects (received Flutamide + Clomiphene Citrate) and group B included 43 subjects (received placebo + Clomiphene Citrate). Ultrasound was carried to determine the size of follicles and growth rate of them during follicular phase of the menstrual cycle. Also, progesterone levels were measured on days 19 and 21 of the menstrual cycle. Results In this study, ninety six PCOS patients, in two treatment and control groups, were evaluated regarding to body mass index (BMI), cycle irregularity, age and number of dominant follicles, duration of stimulation, endocrine profile and score of hirsutism. The obtained results revealed no significant differences between two groups. Conclusion Flutamide does not affect ovulation improvement in PCOS patients undergoing induction (Registration Number: IRCT 201105081141N10).

[1]  V. Tse,et al.  The Female Patient , 2013 .

[2]  S. Domino,et al.  Contemporary medical therapy for polycystic ovary syndrome , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[3]  M. Hill,et al.  Flutamide Suppresses Adrenal Steroidogenesis but Has No Effect on Insulin Resistance and Secretion and Lipid Levels in Overweight Women with Polycystic Ovary Syndrome , 2004, Gynecologic and Obstetric Investigation.

[4]  F. de Zegher,et al.  Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. , 2004, The Journal of clinical endocrinology and metabolism.

[5]  U. Pagotto,et al.  Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome , 2004, Clinical endocrinology.

[6]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[7]  M. Ferin,et al.  Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  F. de Zegher,et al.  Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome. , 2003, Human reproduction.

[9]  A. Paoletti,et al.  The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. , 2002, Fertility and sterility.

[10]  Richard S Legro,et al.  Polycystic ovary syndrome: the new millenium , 2001, Molecular and Cellular Endocrinology.

[11]  E. Diamanti-Kandarakis,et al.  The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.

[12]  G. Morgante,et al.  Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF) , 1998, Clinical endocrinology.

[13]  G. Morgante,et al.  Hormonal effects of flutamide in young women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.